Skip to main content
. 2017 Sep;9(9):3168–3176. doi: 10.21037/jtd.2017.08.53

Table 2. The relationship between DSP, characteristics, and outcomes of patients with non-CF bronchiectasis.

Characteristics DSP <280 (n=10) DSP ≥280 (n=59) P
Age (years) 68.9±10.8 55.4±13.4 0.003
Sex (M/F) 7/3 32/27 0.281
BMI 20.9±4.5 22.2±3.2 0.286
Smoking
   Never 5 50 0.024
   Ex/current 5 9
PFT
   FVC (L) 1.2±0.4 2.1±0.7 0.000
   FEV1 (L) 0.8±0.3 1.6±0.7 0.001
   FEV1/FVC (%) 64.6±12.4 72.0±11.4 0.063
Total IgE 56.9±65.2 70.2±72.7 0.607
ECP (serum) 17.8±11.1 21.4±29.9 0.708
Bacterial colony
   Pseudomonas aeruginosa 3 13 0.255
   Others 0 13
   Normal flora/no growth 7 33
6MWT
   Rest O2 sat (%) 93.2±4.3 95.8±2.0 0.098
   Lowest O2 sat (%) 81.7±10.0 87.7±6.6 0.017
   Walk distances (m) 302.3±38.6 477.5±68.9 0.000
Mortality
   Survivors 3 57 0.000
   Non-survivors 7 2

6MWT, 6-minute walk test; BMI, body mass index; CF, cystic fibrosis; DSP, distance-saturation product; ECP, eosinophilic cationic protein; EID, exercise-induced oxygen desaturation; FEV1, volume that has been exhaled at the end of the first second of forced expiration; FVC, forced vital capacity; IgE, immunoglobulin E; PFT, pulmonary function test.